SLC27A5 and metabolic dysfunction-associated steatotic liver disease: We observed downregulation of hepatic SLC27A5 mRNA expression in patients with NAFLD coupled with fibrosis, non‐alcoholic steatohepatitis (NASH) with fibrosis, and cirrhosis, as displayed in Figure1A.